COTA and PHI, a subsidiary of Texas Oncology, partner to deliver precision medicine for cancer patients

For over a decade, COTA has been tackling the most complicated cancer data to produce real-world data that can power research that will improve care and expand treatment options for patients.

And now, with the integration of AI into our data curation process, we have the potential to do data-assisted clinical research with more speed and accuracy.

But none of this would be possible without trusted partnerships with cancer care providers. We are so grateful to work with Precision Health Informatics, a subsidiary of Texas Oncology, to deploy data-driven precision medicine across their network of cancer centers.

Thanks to Shania Kennedy from Xtelligent Media for writing about our work with Texas Oncology and how we are using real-world data and AI to drive innovation in cancer care.

Link to article: https://www.techtarget.com/healthtechanalytics/feature/How-AI-driven-data-curation-could-advance-precision-medicine